Elsevier

Advances in Genetics

Volume 62, 2008, Pages 185-243
Advances in Genetics

Chapter 4 NMD: Multitasking Between mRNA Surveillance and Modulation of Gene Expression

https://doi.org/10.1016/S0065-2660(08)00604-4Get rights and content

Abstract

Gene expression is a highly specific and regulated multilayer process with a plethora of interconnections as well as safeguard and feedback mechanisms. Messenger RNA, long neglected as a mere subcarrier of genetic information, is more recently recognized as a linchpin of regulation and control of gene expression. Moreover, the awareness of not only proteins but also mRNA as a modulator of genetic disorders has vastly increased in recent years. Nonsense‐mediated mRNA decay (NMD) is a posttranscriptional surveillance mechanism that uses an intricate network of nuclear and cytoplasmic processes to eliminate mRNAs, containing premature termination codons. It thus helps limit the synthesis of potentially harmful truncated proteins. However, recent results suggest functions of NMD that go far beyond this role and affect the expression of wild‐type genes and the modulation of whole pathways. In both respects—the elimination of faulty transcripts and the regulation of error‐free mRNAs—NMD has many medical implications. Therefore, it has earned increasing interest from researchers of all fields of the life sciences. In the following text, we (1) present current knowledge about the NMD mechanism and its targets, (2) define its relevance in the regulation of important biochemical pathways, (3) explore its medical significance and the prospects of therapeutic interventions, and (4) discuss additional functions of NMD effectors, some of which may be networked to NMD. The main focus of this chapter lies on mammalian NMD and resorts to the features and factors of NMD in other organisms if these help to complete or illuminate the picture.

Introduction

After 15 years or so of a somewhat shadowy existence, nonsense‐mediated mRNA decay (NMD) research has only recently left this sheltered realm and has developed into one of the hottest fields both in molecular and cellular biology and in molecular medicine. Both—the previously arcane life of NMD and the present surge of interest also from unexpected directions—are fuelled by the amazing features of this complex and still enigmatic mechanism and its molecular actors. Early on, nonsense mutations were recognized to be linked to or to underlie many human disease phenotypes, yet the most frequent impact of nonsense mutations often escaped (and still escapes) many researchers: contrary to intuition and to the most prevalent interpretation, a premature termination codon (PTC), that is a stop codon within an open reading frame (ORF), does not usually induce the synthesis of a truncated protein to which the observed phenotype could be, and often is, ascribed; instead, it triggers the decay of the mutated mRNA. This phenomenon—that cells already monitor the quality of gene expression products at intermediate steps—is astounding in itself but the way it is enacted is even more prodigous.

To discriminate between termination codons that specify the end of an ORF and those that interrupt it, mammals interlock two pivotal yet spatially separate processes in gene expression: nuclear splicing and cytoplasmic translation. Interestingly, the details differ in various organisms yet the phenomenon of NMD itself is common to all metazoans, thus underscoring its vital significance. Yet, the differences in the details are significant and stress the importance of screening the DNA and protein databases not only for similarities as the most important functional features because evolution has treasured them but also because it is as much difference as kinship that matters in evolution.

NMD is complex. This basic property is evident in a multitude of aspects. First, on the biochemical level, NMD is complex because it combines both nuclear and cytoplasmic events. In addition, NMD seems to dispose of several entrance gates that guide potential substrates to degradation and for these options it uses common yet also divergent sets of molecules. In that respect, NMD may turn out to be paradigmatic for many other cellular processes; cellular systems increasingly present themselves as densely meshed, interactive, dynamic, and flexible networks rather than as linear pathways in which one step has to be completed before the next can occur. It looks as if gene expression is better described as a fluid rather than a stepwise process. Therefore, NMD could serve as a model for the elicudation of principles that also underly many other poorly understood mechanisms; its study could help to purge the too prevalent mechanical perceptions of biochemical processes that have been borrowed from nineteenth‐century industry.

Second, NMD is complex in that it not only serves the recognition and elimination of faulty transcripts but also appears to modulate the expression of a plethora of physiological transcripts. These physiological substrates have one feature in common with their pathological counterparts: they possess a termination codon that is, by NMD standards, conceived as premature. This applies, for example, to the termination codons of upstream ORFs, to termination codons that are followed by splice events in the 3′ untranslated region (UTR), or to termination codons that are introduced into an ORF as the result of somatic DNA rearrangements, alternative splicing, ribosomal frameshifting, or mRNA editing. In some cases, these features are exploited for self‐regulatory mechanisms. For example, when a gene product induces the alternative splicing of its own transcript, a PTC may be introduced into its ORF or a splice junction may be generated 3′ to the termination codon, thus directing the resulting alternative transcript to NMD. Moreover, it is suspected that potentially NMD‐sensitive physiological transcripts can stand at crossing points of pathways or networks and thus modulate such pathways as a whole. This, of course, implies that such a potential “regulator transcript” at the center of a pathway can be either exposed to or concealed from NMD or that NMD itself is regulated so that the putative regulator at times escapes NMD and at others is downmodulated by it. There are indications that both of these options occur.

Third, NMD is complex because with respect to its role in human disease, it is janus‐faced. It can be beneficial for heterozygous carriers of nonsense mutations because it destroys the product of the faulty allele and prevents dominant negative impacts of truncated proteins. Yet, it can also result in the clinical picture of protein deficiency in those cases where it prevents the production of a protein that, albeit truncated, would convey at least a residual function.

Fourth, the intricacy of NMD is enhanced in that it emerges as a biological multiplayer. Single or cohorts of its effectors or maybe even itself as a whole seem to moonlight both in other branches of mRNA metabolism and in apparently unrelated functions.

This chapter presents the current state of knowledge about the mechanism of nonsense‐mediated mRNA decay and its molecular actors. Moreover, it tries to illuminate the intricate network of contacts with other cellular pathways and to pinpoint the switch of function of several of its effectors that moonlight in these other pathways. Finally, it highlights the importance of NMD for the understanding of many opaque genotype–phenotype relationships of human hereditary and acquired disease conditions.

Section snippets

General rules

NMD specifically recognizes and degrades mRNAs with PTCs and thus protects the cell from potentially harmful C‐terminally truncated polypeptides. To accomplish the task of discrimination between premature and physiological termination codons, NMD uses a complicated and stunning network composed of early and late elements of gene expression (reviewed in Conti and Izaurralde, 2005, Hentze and Kulozik, 1999, Lejeune and Maquat, 2005, Maquat, 2004). Premature termination or nonsense codons can be

Targets of NMD

The class of NMD substrates that first comes to mind is mRNAs with an erroneous in‐frame stop codon that interrupts their ORF. PTCs can be acquired by nonsense and frameshift mutations. Furthermore, unproductive somatic DNA rearrangements [in the case of T‐cell receptor (TCR) and immunoglobulin genes], transcriptional errors, and splice errors can result in frameshifts and subsequently in reading frames that terminate prematurely. Other types of faulty transcripts are exemplified by pre‐mRNAs

Disobedient NMD Targets

According to current mechanistic understanding in mammalia, PTCs that reside >50 nt 5′ to the last exon–exon junction should elicit NMD. Consistent with and obedient to this rule, mRNAs transcribed from intronless genes and transcripts with PTCs that reside beyond this border are NMD resistant (Brocke et al., 2002, Maquat and Li, 2001, Neu‐Yilik et al., 2001). However, the picture is more complicated than these results imply. The sensitivity of transcripts to NMD varies widely. As previously

Good Cop, Bad Cop: Medical Importance of NMD

Genetic disorders are commonly caused by nonsense or frameshift mutations that introduce PTCs, and NMD helps to avoid the production of large amounts of C‐terminally truncated peptides. The medical importance of NMD is well documented in β‐thalassemia, which exemplifies the phenotypic impact of the polar effect of PTC mutations at different positions within the same gene (Holbrook et al., 2004 and references therein). If PTC mutations are located at positions that activate NMD, the common

Moonlighting NMD Proteins: Moonlighting Pathway?

NMD factors either alone or in teams entertain a multitude of contacts to other cellular pathways and functions. These range from an as yet poorly understood role of Upf1, Smg‐5, and Smg‐6 in RNAi of C. elegans (Domeier et al., 2000) and of Upf1 in RNAi in plants (Arciga‐Reyes et al., 2006), over roles of various NMD factors in translation, UPF1 functions in nonsense‐associated altered splicing (NAS) (Mendell et al., 2002, Zhang and Krainer, 2006) and in other mRNA turnover pathways, and tasks

Conclusions

Substantial progress has been made in the last decade to elucidate the mechanism of NMD, the factors involved, and their mode of action, as well as to identify pathological and physiological NMD targets. Moreover, the understanding of the multiple functions of NMD has been considerably deepened. However, as is customary in science, each step forward confronts us with new and surprising enigmas. There are several burning issues to tackle. (1) It is an unsolved and important question whether, as

Acknowledgments

The authors thank Jill Holbrook for critical reading of the manuscript and the members of the Kulozik laboratory for insightful and inspiring discussions.

References (221)

  • J. Dostie et al.

    Translation is required to remove Y14 from mRNAs in the cytoplasm

    Curr. Biol.

    (2002)
  • Y. Enokizono et al.

    Structure of hnRNP D complexed with single‐stranded telomere DNA and unfolding of the quadruplex by heterogeneous nuclear ribonucleoprotein D

    J. Biol. Chem.

    (2005)
  • P. Fortes et al.

    The yeast nuclear cap binding complex can interact with translation factor eIF4G and mediate translation initiation

    Mol. Cell

    (2000)
  • N. Fukuhara et al.

    SMG7 is a 14‐3‐3‐like adaptor in the nonsense‐mediated mRNA decay pathway

    Mol. Cell

    (2005)
  • A. Gaba et al.

    Ribosome occupancy of the yeast CPA1 upstream open reading frame termination codon modulates nonsense‐mediated mRNA decay

    Mol. Cell

    (2005)
  • N.H. Gehring et al.

    Y14 and hUpf3b form an NMD‐activating complex

    Mol. Cell

    (2003)
  • N.H. Gehring et al.

    Exon‐junction complex components specify distinct routes of nonsense‐mediated mRNA decay with differential cofactor requirements

    Mol. Cell

    (2005)
  • C.I. Gonzalez et al.

    The yeast hnRNP‐like protein Hrp1/Nab4 marks a transcript for nonsense‐mediated mRNA decay

    Mol. Cell

    (2000)
  • G.W. Hall et al.

    Nonsense codon mutations in the terminal exon of the beta‐globin gene are not associated with a reduction in beta‐mRNA accumulation: A mechanism for the phenotype of dominant beta‐thalassemia

    Blood

    (1994)
  • P.L. Harding et al.

    The influence of antisense oligonucleotide length on dystrophin exon skipping

    Mol. Ther.

    (2007)
  • F. He et al.

    Genome‐wide analysis of mRNAs regulated by the nonsense‐mediated and 5′ to 3′ mRNA decay pathways in yeast

    Mol. Cell

    (2003)
  • M.W. Hentze et al.

    A perfect message: RNA surveillance and nonsense‐mediated decay

    Cell

    (1999)
  • A. Inacio et al.

    Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense‐mediated mRNA decay

    J. Biol. Chem.

    (2004)
  • Y. Ishigaki et al.

    Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense‐mediated decay in mammalian cells are bound by CBP80 and CBP20

    Cell

    (2001)
  • C. Ainsworth

    Nonsense mutations: Running the red light

    Nature

    (2005)
  • N. Amrani et al.

    A faux 3′‐UTR promotes aberrant termination and triggers nonsense‐mediated mRNA decay

    Nature

    (2004)
  • K.R. Anders et al.

    SMG‐5, required for C. elegans nonsense‐mediated mRNA decay, associates with SMG‐2 and protein phosphatase 2A

    EMBO J.

    (2003)
  • M. Arakawa et al.

    Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice

    J. Biochem. (Tokyo)

    (2003)
  • L. Arciga‐Reyes et al.

    UPF1 is required for nonsense‐mediated mRNA decay (NMD) and RNAi in Arabidopsis

    Plant J.

    (2006)
  • C.M. Azzalin et al.

    The double life of UPF1 in RNA and DNA stability pathways

    Cell Cycle

    (2006)
  • C.M. Azzalin et al.

    S. cerevisiae Est1/H. sapiens SMG6 protein family members function in telomere metabolism

  • B.A. Bamber et al.

    The Caenorhabditis elegans unc‐49 locus encodes multiple subunits of a heteromultimeric GABA receptor

    J. Neurosci.

    (1999)
  • L. Banihashemi et al.

    Upf1/Upf2 regulation of 3′untranslated region splice variants of AUF1 links nonsense‐mediated and A+U‐rich element‐mediated mRNA decay

    Mol. Cell Biol.

    (2006)
  • J. Baron‐Benhamou et al.

    Using the lambdaN peptide to tether proteins to RNAs

    Methods Mol. Biol.

    (2004)
  • E.R. Barton‐Davis et al.

    Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

    J. Clin. Invest.

    (1999)
  • J.F. Bateman et al.

    Tissue‐specific RNA surveillance? Nonsense‐mediated mRNA decay causes collagen X haploinsufficiency in Schmid metaphyseal chondrodysplasia cartilage

    Hum. Mol. Genet.

    (2003)
  • D.M. Bedwell et al.

    Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line

    Nat. Med.

    (1997)
  • I. Behm‐Ansmant et al.

    NMD in Drosophila: A snapshot into the evolution of a conserved mRNA surveillance pathway

  • I. Behm‐Ansmant et al.

    Quality control of gene expression: A stepwise assembly pathway for the surveillance complex that triggers nonsense‐mediated mRNA decay

    Genes Dev.

    (2006)
  • A. Bhattacharya et al.

    Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense‐mediated mRNA decay

    RNA

    (2000)
  • L. Bidou et al.

    Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment

    Gene Ther.

    (2004)
  • A.M. Borman et al.

    Biochemical characterisation of cap‐poly(A) synergy in rabbit reticulocyte lysates: The eIF4G‐PABP interaction increases the functional affinity of eIF4E for the capped mRNA 5′‐end

    Nucleic Acids Res.

    (2000)
  • K.A. Bremer et al.

    An endonuclease activity similar to Xenopus PMR1 catalyzes the degradation of normal and nonsense‐containing human beta‐globin mRNA in erythroid cells

    RNA

    (2003)
  • K.S. Brocke et al.

    The human intronless melanocortin 4‐receptor gene is NMD insensitive

    Hum. Mol. Genet.

    (2002)
  • S. Brogna

    Nonsense mutations in the alcohol dehydrogenase gene of Drosophila melanogaster correlate with an abnormal 3′ end processing of the corresponding pre‐mRNA

    RNA

    (1999)
  • M. Buhler et al.

    Efficient downregulation of immunoglobulin mu mRNA with premature translation‐termination codons requires the 5′‐half of the VDJ exon

    Nucleic Acids Res.

    (2004)
  • M. Buhler et al.

    EJC‐independent degradation of nonsense immunoglobulin‐mu mRNA depends on 3′ UTR length

    Nat. Struct. Mol. Biol.

    (2006)
  • M. Buisson et al.

    The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon

    Hum. Mutat.

    (2006)
  • A. Buzina et al.

    Infrequent translation of a nonsense codon is sufficient to decrease mRNA level

    Mol. Biol. Cell

    (1999)
  • B.M. Cali et al.

    smg‐7 is required for mRNA surveillance in Caenorhabditis elegans

    Genetics

    (1999)
  • Cited by (61)

    • SMG1 regulates adipogenesis via targeting of staufen1-mediated mRNA decay

      2013, Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
      Citation Excerpt :

      Consequently, the reduction in the level of KLF2 allows for efficient adipogenesis (Fig. 7, bottom). In the case of NMD, it is generally accepted that SMG1 phosphorylates Upf1 within the SURF complex recruited during translation termination [1–4]. Although we proposed the above model for SMD, the possibility that free SMG1 phosphorylates free Upf1 before formation of the SURF complex cannot be ruled out.

    • Regulation of gene expression in mammalian nervous system through alternative pre-mRNA splicing coupled with RNA quality control mechanisms

      2013, Molecular and Cellular Neuroscience
      Citation Excerpt :

      Interestingly, requirements for specific NMD factors may differ for different targets and some mammalian mRNAs containing long 3′UTRs may undergo NMD in an EJC-independent manner (Chang et al., 2007; Huang and Wilkinson, 2012; Isken and Maquat, 2007; Nicholson et al., 2010). Besides its role in eliminating aberrant mRNAs, NMD is known to contribute to gene regulation programs through an alternative splicing-dependent mechanism referred to as AS-NMD or sometimes RUST (from “regulation by unproductive splicing and translation”) (Lareau et al., 2007a; McGlincy and Smith, 2008; Neu-Yilik and Kulozik, 2008). Different estimates predict that AS-NMD may control the abundance of ~ 2% to 35% of alternatively spliced transcripts with a considerable fraction of regulated splicing events showing interspecies conservation (Baek and Green, 2005; de Lima Morais and Harrison, 2010; Green et al., 2003; Lewis et al., 2003; Mudge et al., 2011; Pan et al., 2006; Zhang et al., 2009).

    View all citing articles on Scopus
    View full text